z-logo
open-access-imgOpen Access
Combinatorial assessment of ctDNA release and mutational burden predicts anti‐PD(L)1 therapy outcome in nonsmall‐cell lung cancer
Author(s) -
Fang Wenfeng,
Ma Yuxiang,
Yin Jiani C.,
Zhou Huaqiang,
Wang Fufeng,
Bao Hua,
Wang Ao,
Wu Xue,
Hong Shaodong,
Yang Yunpeng,
Huang Yan,
Zhao Hongyun,
Shao Yang W.,
Zhang Li
Publication year - 2020
Publication title -
clinical and translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2001-1326
DOI - 10.1002/ctm2.8
Subject(s) - medicine , liquid biopsy , immunotherapy , biomarker , lung cancer , oncology , cancer , disease , immune checkpoint , targeted therapy , circulating tumor cell , bioinformatics , biology , metastasis , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here